awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39255218-61930E3B-09CE-4BCA-9B2F-4783EF97A2BC
Q39255218-61930E3B-09CE-4BCA-9B2F-4783EF97A2BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255218-61930E3B-09CE-4BCA-9B2F-4783EF97A2BC
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy.
P2860
Q39255218-61930E3B-09CE-4BCA-9B2F-4783EF97A2BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39255218-61930E3B-09CE-4BCA-9B2F-4783EF97A2BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a4057ecd1bb86321da419205b57f1c05eecca70
P2860
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.